GNTA
Genenta Science SpA ADR
NASDAQ: GNTA · HEALTHCARE · BIOTECHNOLOGY
$0.71
-1.99% today
Updated 2026-04-29
Market cap
$16.71M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.39
Dividend yield
—
52W range
$1 – $6
Volume
0.1M
Genenta Science SpA ADR (GNTA) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total assets | $21.35M | $17.50M | $40.03M | $33.44M | $22.35M | $14.82M |
| Cash & equivalents | $20.14M | $15.47M | $37.24M | $29.79M | $3.69M | $4.58M |
| Current assets | $20.60M | $16.53M | $38.76M | $31.72M | $21.26M | $14.47M |
| Total liabilities | $2.50M | $2.35M | $1.17M | $2.30M | $1.91M | $2.33M |
| Current liabilities | $2.49M | $2.33M | $1.14M | $2.18M | $1.74M | $2.10M |
| Long-term debt | — | — | — | — | — | — |
| Shareholder equity | $18.85M | $15.15M | $38.86M | $31.14M | $20.43M | $12.50M |
| Retained earnings | $-15.90M | $-21.49M | $-27.02M | $-35.47M | $-47.14M | $-56.06M |
| Accounts receivable | $429589.00 | $760631.00 | $1.42M | $1.56M | $2.00M | $1.45M |
| Inventory | $-163491.00 | $27671.00 | $76256.00 | $144689.00 | $2.00 | — |
| Goodwill | — | — | — | — | $-34656.00 | — |